The Leading Company in the World, PolarisAIPharma Co., Ltd.!

We have been devoting to all our energies to the development
of new active pharmaceutical ingredient

Research研究開発

研究活動

  • HOME
  • 研究開発
  • 研究活動
Year Achievements
2017 Antiemetic - Ramosetron hydrochloride
Nootropics & Neurotonics - Choline Alfoscerate
Diuretic - Azosemide
2016 Antiviral - Tenofovir Disoproxil
Antidepressant - Duloxetine Hydrochloride
Antiasthmatic - Montelukast Sodium
2015 Antipsychotic - Aripiprazole
Antioxidant - Sodium Selenite Pentahydrate
Treatment of BPH - Silodosin
New drug intermediate - MPC
2014 Antihypertensive - Olmesartan Medoxomil
Antiviral - Entecavir
Antilipemic - Rosuvastatin Calcium
MRI contrast agent - Gadopetetate Dimeglumine
2013 Antiulcerative - Lafutidine
Antioxidant - Selenious acid
Nootropics & Neurotonics - N-acetyl-L-aspartic acid
New drug intermediate - BIP
2012 Antidepressant - Fluvoxamine Maleate
Antilipemic - Pitavastatin Calcium
2011 Antihistaminic - Ebastine
New drug intermediate - DCP
2010 Gastroprokinetic - Mosapride Citrate Hydrate
Antihypertensive drugs - Bunazosin
2009 Antiulcerants - Rebamipide
Antidiabetic - Pioglitazone hydrochloride
2008 Antiasthmatic - Pranlukast hydrate
2007 Drugs for erectile dysfunction - Mirodenafil Hydrochloride
Digestive medicine - Magnesium Dimecrotate
2006 MRI contrast agent - Gadodiamide
Treatment of Urinary Incontinence - Tolterodine L-Tartrate
2005 Anticonvulsants - Gabapentin
Anticonvulsants - Topiramete